These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2798789)

  • 1. [Assessment of the biological efficacy of fractionated HDR (high dose rate)-afterloading using the linear-quadratic equation].
    Glaser FH; Möldner B
    Radiobiol Radiother (Berl); 1989; 30(4):305-9. PubMed ID: 2798789
    [No Abstract]   [Full Text] [Related]  

  • 2. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
    King CR
    Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
    Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
    Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose rate brachytherapy for prostate cancer.
    Hoskin P
    Cancer Radiother; 2008 Nov; 12(6-7):512-4. PubMed ID: 18755623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Developments in brachytherapy].
    Ikeda H
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1317-23. PubMed ID: 7668864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: a retrospective study.
    Kubo T; Sugita T; Shimose S; Matsuo T; Hirao K; Kimura H; Kenjo M; Ochi M
    BMC Cancer; 2005 Jul; 5():79. PubMed ID: 16026629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
    Armpilia C; Dale RG; Sandilos P; Vlachos L
    Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Present and future in brachytherapy--from the discovery of radium to the 21st century].
    Inoue T; Inoue T
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1254-60. PubMed ID: 10478177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gynecologic brachytherapy--from low-dose-rate to high-tech].
    Herrmann T; Christen N; Alheit HD
    Strahlenther Onkol; 1993 Mar; 169(3):141-51. PubMed ID: 8465248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of temporal dose distribution in prolonged and fractionated brachytherapy of gynecologic tumors. Mathematically formulated models and clinical experiences in fractionated short-time-afterloading with high dose rates].
    Glaser FH; Grimm D; Heider KM
    Radiobiol Radiother (Berl); 1984; 25(2):231-40. PubMed ID: 6739765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preoperative low-dose-rate versus high-dose-rate brachytherapy in stage IB cervix cancer. An efficacy study].
    Mayer A; Nemeth G; Nemeskeri C; Thalacker U
    Strahlenther Onkol; 1993 Dec; 169(12):716-20. PubMed ID: 8284743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The results of primary HDR-afterloading brachytherapy in corpus carcinoma].
    Knocke TH; Kucera H; Weidinger B; Höller W; Pötter R
    Strahlenther Onkol; 1995 Apr; 171(4):195-201. PubMed ID: 7740406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative high-dose-rate brachytherapy in the prevention of keloids.
    Veen RE; Kal HB
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1205-8. PubMed ID: 17967309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aspects of the chronological dose distribution in the radiobiology and radiotherapy.
    Ulmer W
    Strahlenther Onkol; 1986 Jun; 162(6):374-86. PubMed ID: 3738738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A graphical method to simplify the application of the linear-quadratic dose-effect equation to fractionated radiotherapy.
    Dale RG
    Br J Radiol; 1986 Nov; 59(707):1111-5. PubMed ID: 3790899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The behavior of the activation parameters of plasma coagulation under HDR-afterloading therapy in patients with endometrial carcinoma].
    Münstedt K; Kemkes-Matthes B; Matthes KJ; Vahrson H
    Strahlenther Onkol; 1996 Jan; 172(1):39-42. PubMed ID: 8571186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.